While no repurposed or novel SARS-CoV-2 inhibitors have yet been identified with SBDD tools, an important trend has emerged that involves applying supercomputing resources to COVID-19 drug discovery.
← all excerpts
A critical overview of computational approaches employed for COVID-19 drug discovery.
1
—
—